Treatment With Tildren®

(tiludronate disodium)

Tildren® (tiludronate disodium) will be administered to your horse through an intravenous infusion. It is administered over a 90-minute period.

Tildren® is most effective when used in conjunction with corrective farriery and a controlled exercise program. Visit with your veterinarian to learn more about management and care after Tildren® has been given.

Get in Touch

Questions? Call us at 1-888-524-6332 or email us at This email address is being protected from spambots. You need JavaScript enabled to view it.

Amy Bell
West
This email address is being protected from spambots. You need JavaScript enabled to view it.

Mark Glassford
South
This email address is being protected from spambots. You need JavaScript enabled to view it.

Rory Boren
Central
This email address is being protected from spambots. You need JavaScript enabled to view it.

Jim Conway
Southeast
This email address is being protected from spambots. You need JavaScript enabled to view it.

Archie McNeil
Northeast
This email address is being protected from spambots. You need JavaScript enabled to view it.

Equine Territories

Do not use in horses with impaired renal function or with a history of renal disease. NSAIDs should not be used concurrently with TILDREN® . Concurrent use of NSAIDs with TILDREN® may increase the risk of renal toxicity and acute renal failure. Horses should be observed closely for 4 hours post-infusion for the development of clinical signs consistent with colic or other adverse reactions.

Caution should be used when administering TILDREN® to horses with conditions affecting mineral or electrolyte homeostasis (e.g. HYPP, hypocalcemia) and conditions which may be exacerbated by hypocalcemia (e.g. cardiac disease). The safe use of TILDREN® has not been evaluated in horses less than 4 years of age, in pregnant or lactating mares, or in breeding horses. See package insert for full prescribing information.